Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
about
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityGenetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary SyndromeEndocrine causes of nonalcoholic fatty liver diseaseInsulin receptor signaling in normal and insulin-resistant statesMetabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissueDisordered follicle developmentMetabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with InositolsScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Should all women with PCOS be treated for insulin resistance?Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistanceInvolvement of growth factors in the pathophysiology of polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.The insulin receptor--a critical link in glucose homeostasis and insulin action.Skeletal muscle insulin resistance in endocrine disease.Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndromeInsulin resistance is not conserved in myotubes established from women with PCOS.Polycystic ovarian syndrome in women with epilepsy: a review.Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.Epidemiology, diagnosis, and management of polycystic ovary syndromeThe influence of obesity on hyperandrogenism and infertility in the female.Polycystic ovary syndrome in the pediatric populationThe Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinthSNP analysis of follistatin gene associated with polycystic ovarian syndromeMetabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome.Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatinPeripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids.Insulin resistant states and insulin signaling.Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.Genetic and environmental aspect of polycystic ovary syndrome.Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome.Loss of PKBβ/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo.Genetic variation in insulin-induced kinase signalingGenetics of polycystic ovary syndrome: searching for the way out of the labyrinth.Serum leptin elevation in obese women with PCOs: a continuing controversyImproved responsiveness of PCOS patients to clomiphene after CYP17a inhibitorCardiometabolic aspects of the polycystic ovary syndrome.Early impaired β-cell function in chinese women with polycystic ovary syndrome.
P2860
Q24197673-81BEEE51-76EC-45F3-B11E-ACA3DDF292F8Q24240654-EC3820CA-D9BE-494F-8314-3618A646B57DQ26745164-3BA1EFF6-15DA-4C50-9990-A4E447400B5FQ26780254-97D91F32-A9B1-4D08-80E5-D84892B4A26AQ26823171-2E1CC8CF-AD53-42F1-A44F-2454D740F661Q26830631-4CAA25E1-6E46-48E2-B365-3E7D7467435EQ26851230-11787BC2-918B-4F1E-9ADE-440FE72057B6Q28072474-B133FBAB-A739-453F-AB98-7F5698CB29CAQ28390200-F2653F1D-CD54-4061-8B5C-34F15542C32DQ30423117-CDF1B15A-9C4F-4099-9FB4-257B20258DF7Q33402910-42BD1F4E-5AF5-4C78-9770-C600C99CDE50Q33538168-06D3CF97-0F49-4B96-B393-03DAFA61B35CQ33569169-8D25DF7E-2B9A-454D-A12F-A54E7E12C25BQ33599394-47C1CA41-DD2D-4462-A70E-4A3F649B0246Q33734293-D5FA8A3C-DB62-4BF4-81EE-752B016B2C47Q33751592-5743A6ED-E0F7-47B8-BB64-E9047FAA5B3AQ33786857-D8302FC4-BC45-4A88-B940-3AAD086A3AB6Q34345051-8075A3EF-EB60-4DFB-B4AC-419835D02214Q34647418-3DC100C1-643E-4717-A82B-C81634B7B88AQ34658641-9015B29A-9AE4-4E33-B508-22AA35D0E4C0Q34742759-1186A7CE-0AAA-4431-8869-706CB0015EEFQ35075035-D88A7F6F-67A0-4C42-AAED-9FC57DFB9220Q35100131-3F72C512-B3A8-4C91-8F8F-83628D56BE47Q35100161-B0FB8512-D93C-48B6-A5AB-AF5C5F421049Q35205530-8054A71D-614A-44A4-8CEB-128282402DEAQ35535653-E056CC4E-09F7-4769-979E-28F639037FDDQ35556131-3505E017-17D2-4028-ACD7-FF4A8A69153FQ35572930-E43ACE03-9DE2-49C6-9C86-B339EA83AB2FQ35576057-4C75F8FD-05D7-4417-BF88-5BEBEFF9BAE8Q35599772-7AF70B40-84ED-487F-A9B1-50ABAD981B3AQ35676497-C05D2CE0-251E-45DB-A6EC-60C3F50CAFEEQ35685428-87BB70E9-6C1A-48C0-ACDD-C5626C4828FEQ35687495-55648D6F-344F-4E95-9921-70837BFE06A4Q35921170-767F39AC-ED1A-4A0D-A73B-20F889729450Q35991493-C8B3C283-3C1F-431E-988B-4ECDC1D0305AQ36182579-F9F1E7A3-BD25-42F3-AEA4-6C15BD615553Q36269624-643A9230-44EE-4445-A4B2-B1C127DF1CAAQ36271430-0B86EDAC-10E1-4CFC-8ED5-807C2A3D00BDQ36287892-D9CA2087-0284-473B-97CB-FDD48A2C6695Q36305369-41D8F72A-0687-424D-A04E-F2065EBB4B1A
P2860
Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@ast
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@en
type
label
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@ast
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@en
prefLabel
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@ast
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@en
P2093
P2860
P356
P1476
Excessive insulin receptor ser ...... the polycystic ovary syndrome.
@en
P2093
P2860
P304
P356
10.1172/JCI118126
P407
P577
1995-08-01T00:00:00Z